Sunday, December 21, 2014

Top High Dividend Companies To Buy For 2014

Investors have sought out the highest dividend paying stocks they can find in order to maximize their income in a low-interest rate environment. But despite the popularity of high-yield dividend stocks, their laser focus on current yield at the expense of other desirable characteristics often make them less-than-ideal long-term investments.

Too much of a good thing?
In general, dividend paying stocks are a great place for investors to start in their quest for solid investment opportunities. By paying a dividend, a company demonstrates its ability to generate dependable cash flow as well as its commitment to reward shareholders for investing in its stock. Moreover, companies tend to want to avoid making dividend cuts in the future, and so they tend to wait until they're absolutely sure that they'll be able to sustain their quarterly payouts before they initiate or boost a dividend.

But companies that pay high dividend yields often don't have the same favorable traits you'll find in their lower-yielding counterparts. All too often, a high yield comes about because of a decline in the company's overall business prospects that sends the stock price plunging. Although companies sometimes are able to sustain dividend levels even in light of faltering business conditions, the highest dividend paying stocks usually succumb to the pressure to reduce their payouts.

Hot Safest Companies To Watch In Right Now: Andatee China Marine Fuel Services Corporation(AMCF)

Andatee China Marine Fuel Services Corporation, through its subsidiaries, engages in the production, storage, distribution, and wholesale purchase, and sale of blended marine fuel oil for cargo and fishing vessels primarily in Tianjin City, and Liaoning, Shandong, and Zhejiang Provinces in the People?s Republic of China. It sells its products through distributors, as well as to retail customers. The company was founded in 1997 and is based in Dalian, the People?s Republic of China.

Advisors' Opinion:
  • [By Lisa Levin]

    Andatee China Marine Fuel Services (NASDAQ: AMCF) shares touched a new 52-week high of $3.08 on Q2 results.

    CRA International (NASDAQ: CRAI) shares reached a new 52-week high of $26.845. CRA International shares have jumped 45.84% over the past 52 weeks, while the S&P 500 index has gained 18.08% in the same period.

  • [By Roberto Pedone]

    Andatee China Marine Fuel Services (AMCF) is engaged in the production, storage, distribution and wholesale purchases and sales of blended marine fuel oil for cargo and fishing vessels. This stock closed up 4.1% to $1.27 in Thursday's trading session.

    Thursday's Range: $1.22-$1.32

    52-Week Range: $0.45-$2.75

    Thursday's Volume: 150,000

    Three-Month Average Volume: 193,369

    From a technical perspective, AMCF spiked sharply higher here with lighter-than-average volume. This move is quickly pushing shares of AMCF within range of triggering a major breakout trade. That trade will hit if AMCF manages to take out Thursday's high of $1.32 to its 50-day moving average of $1.39 with high volume.

    Traders should now look for long-biased trades in AMCF as long as it's trending above some key near-term support levels at $1.15 or at $1.09 and then once it sustains a move or close above those breakout levels with volume that hits near or above 193,369 shares. If that breakout hits soon, then AMCF will set up to re-test or possibly take out its next major overhead resistance levels at $1.80 to $1.98. Any high-volume move above those levels will then give AMCF a chance to re-test its 52-week high at $2.75.

  • [By Lisa Levin]

    Andatee China Marine Fuel Services (NASDAQ: AMCF) shares surged 70.29% to $2.98 after the company reported Q2 results.

    Monster Beverage (NASDAQ: MNST) shares climbed 30.97% to $93.84. Coca-Cola Company (NYSE: KO) and Monster Beverage announced a long-term strategic partnership. As part of the deal, Coca-Cola will buy a 16.7% equity stake in Monster.

Top High Dividend Companies To Buy For 2014: Thoratec Corporation(THOR)

Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The company?s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge, and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising hom e discharge, and post-cardiotomy myocardial recovery. The company also provides CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure. In addition, it offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. The company sells its products through direct sales force in the United States, as well as through a network of distributors internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

Advisors' Opinion:
  • [By Anna Prior]

    Medical device company Thoratec Corp.(THOR) has purchased Apica Cardiovascular Ltd., in a deal that includes $35 million in cash upfront and potential milestone payments of up to $40 million.

Top High Dividend Companies To Buy For 2014: First Trust Portfolios LP (QQEW)

First Trust NASDAQ-100 Equal Weighted Index Fund (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the NASDAQ-100 Equal Weighted Index (the Index). The Fund will normally invest at least 90% of its assets in common stocks that comprise the Index. The Index is the equal-weighted version of the NASDAQ-100 Index, which includes 100 of the largest non-financial securities listed on NASDAQ based on market capitalization. The Index contains the same securities as the NASDAQ-100 Index but each of the securities is initially set at a weight of 1% of the Index and is rebalanced quarterly. The Fund�� investment advisor is First Trust Advisors L.P. Advisors' Opinion:
  • [By Selena Maranjian]

    Perhaps the best reason to pass up this otherwise solid ETF is its market-cap-based weighting, which gives much more influence to some companies than others. If you're not a strong believer in Apple's future, for example, you may not want more than 13% of your money in this ETF tied up in it. If you agree that equal weighting makes more sense in indexes, consider the First Trust NASDAQ-100 Equal Weighted ETF (NASDAQ: QQEW  ) , an ETF with the same stock focus as the PowerShares ETF that's also compelling in terms of fees and performance. It charges a bit more in fees, but it will give all its holdings an equal shot at boosting the value of the index.

Top High Dividend Companies To Buy For 2014: Achillion Pharmaceuticals Inc.(ACHN)

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.

Advisors' Opinion:
  • [By Keith Speights]

    Hold horrors
    Achillion Pharmaceuticals (NASDAQ: ACHN  ) takes the worst spot this week. Shares plunged 62% on bad news from the U.S. Food and Drug Administration.

  • [By Lisa Levin]

    Achillion Pharmaceuticals (NASDAQ: ACHN) shares touched a new 52-week high of $9.36 on hepatitis C drug study.

    Andatee China Marine Fuel Services (NASDAQ: AMCF) shares touched a new 52-week high of $3.08 on Q2 results.

  • [By Dan Carroll]

    Few biotechs were hit as hard as Achillion Pharmaceuticals (NASDAQ: ACHN  ) this week, however. Achillion makes up around 2% of the weight of the SPDR Biotech ETF, and its 7.5% loss this week was a major reason for the fund's fall. This stock has failed to capitalize on the markets' surge this year, losing 10% year-to-date. The company only recently named a new CEO, lifting its former R&D head and chief science officer to the top job. Achillion's still in the developmental stage of its life and thus produces no revenue, and the company's cash burn makes it seem likely that more share dilution is on its way as the company looks to advance its hepatitis-C pipeline over the coming years. Until Achillion produces some meaningful results from that pipeline, this stock will remain a risky play in an already risky space.

  • [By Lisa Levin]

    Achillion Pharmaceuticals (NASDAQ: ACHN) rose 14.34% to $9.65 after the company reported that it has achieved 100% sustained virologic response rate from an eight week Phase 2 trial evaluating a ribavirin-free regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV.

Top High Dividend Companies To Buy For 2014: Homex Development Corp (HOMEX*)

Desarrolladora Homex SAB de CV is a Mexico-based homebuilding company. Together with its subsidiaries, the Company is mainly engaged in the promotion, design, development, construction and sale of affordable entry level and middle income residential housing. The Company has four divisions: the Mexico Division; the International Division; the Infrastructure Division, and the Tourism Division. To carry out its activities, the Company engages in land acquisition, obtaining permits and licenses, designing, constructing, marketing and selling homes, obtaining individual financing for its customers and developing communities to satisfy housing needs in Mexico. The Company participates in housing supply offers from the main housing funds in Mexico. Advisors' Opinion:
  • [By Julia Leite]

    Industrias CH gained 7.9 percent to 85.55 pesos today. Homex (HOMEX*) climbed 5.4 percent to 8.16 pesos, extending this week�� gains to 16 percent. Urbi gained 7.2 percent to 2.37 pesos today, advancing 16 percent in the past five days. Corp. Geo gained 1.5 percent today to 5.55 pesos, climbing 14 percent for the week.

Top High Dividend Companies To Buy For 2014: Morgan Stanley(MS)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. It operates in three segments: Institutional Securities, Global Wealth Management Group, and Asset Management. The Institutional Securities segment offers financial advisory services on mergers and acquisitions, divestitures, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers, and leveraged buyouts and takeover defenses, as well as shareholder relations, capital raising, corporate lending, and investments. This segment also engages in sales, trading, financing, and market-making activities, including equity trading, commodities, and interest rates, credit, and currencies, as well as financing services, such as prime brokerage, consolidated clearance, settlement, custody, financing, and portfolio reporting services. The Global Wealth Management Group segment provide s brokerage and investment advisory services covering various investment alternatives comprising equities, options, futures, foreign currencies, precious metals, fixed income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs; education savings programs, financial and wealth planning services, and annuity and insurance products; credit and other lending products; cash management services; retirement services; and trust and fiduciary services. The Asset Management segment offers products and services in equity, fixed income, and alternative investments, such as hedge funds, fund of funds, real estate, private equity, and infrastructure to institutional and retail clients through proprietary and third party distribution channels. This segment also involves in investment and merchant banking activities. The company was founded in 1935 and is headq uartered in New York.

Advisors' Opinion:
  • [By WWW.DAILYFINANCE.COM]

    Shutterstock It's pretty clear bonds are a bad job, with returns relatively meager and prices likely to fall ahead, but yield-seeking investors keep pushing money their way. "People have been buying bonds for some years and going further out the risk spectrum to get yield as Treasury yields fall," said Mark Matthews, head of research for Asia at Julius Baer. Bond yields move inversely to their prices. "There's not a lot of value left in fixed income in general, not just the high yield," he said. "With the Federal Reserve tapering [its asset purchases] and looking to raise rates next year, the price appreciation we've seen generally over the last five years [will reverse] and prices will fall as yields head up," Matthews said. That hasn't stopped investors from chasing bonds' payouts. So far this year, $56.69 billion has flowed into bond funds, outpacing the $44.06 billion heading into equities, according to data from Jefferies. All those funds chasing what appear to be ever-smaller yields have kept bonds expensive and sometimes crowded. "Investment grade credit is trading rich and looks increasingly vulnerable to rising rates," Morgan Stanley (MS) said in a note last week. "Upside appears very limited in high yield, and a negative shock [emerging market turmoil, weaker China or domestic growth etc.] is possible." Others are concerned about the move further out the yield spectrum. "The yields that you're getting over government bonds have reduced dramatically. We're not at record-tight levels but we're not that far away," Steve Goldman, managing director at Kapstream Capital, a fixed income fund manager with $7 billion under management, told CNBC last week. "What it's meant that investors are moving toward greater and greater risk in order to pick up slightly higher yields. And you've got to be careful because the quality of the issuance in that high yield or junk space is going down," he added. Just how much risk are investors chasing? The Internat

  • [By Lauren Pollock]

    Jefferies Group LLC’s fiscal fourth-quarter earnings jumped 68% on strong investment banking revenue. Part of Leucadia National Corp.(LUK), it is often seen as something of a barometer for larger rivals Goldman Sachs Group Inc.(GS) and Morgan Stanley(MS). Chief Executive Richard B. Handler said the company finished the year strongly and fixed income improved significantly from the third quarter.

Top High Dividend Companies To Buy For 2014: Glencore Xstrata PLC (GLCNF.PK)

Glencore Xstrata Plc is a diversified natural resource company. The Company operates in three segments: Metals and Minerals, which includes copper, nickel, zinc/lead, alloys, alumina/aluminum and iron ore; Energy Products, which includes controlled and non-controlled coal mining and oil production operations and investments in strategic handling, storage and freight equipment and facilities, and Agricultural Products, which focuses on grains, oils/oilseeds, cotton and sugar. The Company�� operations consist of over 150 mining and metallurgical sites, offshore oil production assets, farms and agricultural facilities. The Company is a producer and marketer of over 90 commodities, such as mobile phones, bicycles, cutlery, plastics and electricity. Effective January 2, 2014, Post Holdings Inc acquired Agricore United Holdings Inc from Viterra Inc, a unit of Glencore Xstrata PLC, and the transaction also included Dakota Growers Pasta Company, Inc. Advisors' Opinion:
  • [By Pendulum]

    Century Aluminum was founded in 1995 as a part of Glencore (GLCNF.PK). In 1996, Century Aluminum became a public company. As of December 31, 2012:

    "Glencore beneficially owned approximately 41.8% of our outstanding common stock and all of our outstanding Series A Convertible Preferred Stock. Through its ownership of common and preferred stock, Glencore has an overall 46.6% economic ownership of Century." (Source: Century Aluminum 2012 10-K)

No comments:

Post a Comment